Jayanthy and colleagues evaluated the predictive performance of CRP in patients with COVID-19 and a subgroup of diabetes mellitus patients and demonstrated a discrimination of 0.72 in this subgroup [26]. The gene discussed is CRP; the disease is diabetes mellitus.